Health Catalyst (HCAT) Announces Proposed $225M Share Offering
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/1/2026
- Wall Street closes sharply lower as AI cash burn fears spark tech selloff
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil jumps 2%, settles at 6-month highs on fears of escalation in Iran
- Qualcomm shares fall on Intel warning and legal concerns
- Marvell Technology shares drop on Lumentum deal concerns
- Wall Street closes sharply lower as AI cash burn fears spark tech selloff
- Oracle shares drop on AI spending concerns and Microsoft criticism
- SpaceX stock drops on launch setback and sector selloff
- After-Hours Movers: AMZN, TWLO, INTC, SNDK, RDDT, RBLX, PINS, RIVN, SBUX, ILMN
- After-Hours Movers: GOOGL, MSFT, NOW, KLAC. CMG, CVNA, TDOC
- After-Hours Movers: STX, ENPH, HOOD, V, CSGP, BOOM, CAKE, PPG, OI, TER
- After-Hours Movers: CLS, AVGO, CDNS, AMKR, WHR
- After-Hours Movers: WDC, BE, DECK, FIX, RNG
Health Catalyst (HCAT) Prices 4.25M Share Offering at $53/sh
August 11, 2021 5:44 AM EDTHealth Catalyst, Inc. (Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced the pricing of an underwritten public offering of 4,245,283 shares of its common stock at a public offering price of $53.00 per share. The gross proceeds to Health Catalyst from the offering are expected to be approximately $225.0 million, before deducting underwriting discounts and commissions and estimated offering expenses payable by Health Catalyst. In addition, Health Catalyst has granted the underwriters a 30-day option to purchase up to an... More
Health Catalyst Inc. (HCAT) PT Raised to $66 at Piper Sandler
August 6, 2021 9:06 AM EDTPiper Sandler analyst Sean Wieland raised the price target on Health Catalyst Inc. (NASDAQ: HCAT) to $66.00 (from $57.00) while maintaining a Overweight rating.... More
Health Catalyst Inc. (HCAT) PT Raised to $66 at Stifel
August 6, 2021 8:58 AM EDTStifel analyst David Grossman raised the price target on Health Catalyst Inc. (NASDAQ: HCAT) to $66.00 (from $57.00) while maintaining a Buy rating.... More
Health Catalyst Inc. (HCAT) PT Raised to $64 at Canaccord Genuity
August 6, 2021 7:42 AM EDTCanaccord Genuity analyst Richard Close| raised the price target on Health Catalyst Inc. (NASDAQ: HCAT) to $64.00 (from $60.00) while maintaining a Buy rating.... More



